rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1989-7-5
|
pubmed:abstractText |
Thirty-one patients affected by advanced ALL entered this study. Twenty (1 in I CR, 9 in II CR, 6 in III CR and 4 extramedullary relapses) were treated with the BMVC conditioning regimen. Eleven (9 in II CR, 2 in III CR) received the Busulfan plus Cytoxan conditioning regimen. Asta-Z 7654-purged marrow was reinfused at day 0. Both protocols were well tolerated. Two patients treated with the BMVC regimen died in aplasia from sepsis; 1 patient died in CR 5 months after transplantation, 13 relapsed after a median time of 4 months (range 1-31). Four patients are in CCR with a median follow-up of 16 months (range 11-24). In the BU + CY treated group no toxic deaths were observed. Four patients relapsed after a median of 3 months (range 2-7) and 7 are in CCR with a median follow-up of 5 months (range 2-28).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0390-6078
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
67-70
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2498186-Adolescent,
pubmed-meshheading:2498186-Adult,
pubmed-meshheading:2498186-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2498186-Bone Marrow Transplantation,
pubmed-meshheading:2498186-Busulfan,
pubmed-meshheading:2498186-Carmustine,
pubmed-meshheading:2498186-Child,
pubmed-meshheading:2498186-Combined Modality Therapy,
pubmed-meshheading:2498186-Cyclophosphamide,
pubmed-meshheading:2498186-Cytarabine,
pubmed-meshheading:2498186-Drug Resistance,
pubmed-meshheading:2498186-Etoposide,
pubmed-meshheading:2498186-Female,
pubmed-meshheading:2498186-Humans,
pubmed-meshheading:2498186-Male,
pubmed-meshheading:2498186-Mitoxantrone,
pubmed-meshheading:2498186-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:2498186-Preoperative Care,
pubmed-meshheading:2498186-Transplantation, Autologous
|
pubmed:articleTitle |
Results of two different conditioning regimens followed by ABMT in refractory acute lymphoblastic leukemia.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|